ETF BBH VANECK BIOTECH ETF - USD
Add to a list
To use this feature you must be a member
Log inSign up

News VanEck Biotech ETF - USD

ETF

BBH

US92189F7261

Market Closed - Nasdaq
Other stock markets
 21:15:00 03/05/2024 BST 		5-day change 1st Jan Change
164.2 USD +2.25% Intraday chart for VanEck Biotech ETF - USD +5.52% -0.68%
2020 VanEck Vectors Biotech ETF Announces 2020 Annual Distribution, Payable on December 28, 20200.6 CI
2019 VanEck Vectors Biotech ETF Announces Preliminary Year End Estimated Distribution, Payable on December 30, 2019 CI

All the latest ETF news

ETFS Capital Limited Launches a Website to Communicate with Shareholders of WisdomTree CI
ETFS Capital Limited Solicit Proxies to the Shareholders of WisdomTree CI
Ex-Odey portfolio manager Hanbury warns investors are 'buying blind' RE
US equity funds witness outflows for fifth week in a row RE
Global equity funds attract robust weekly inflows, led by Asia RE
Investors flood into Taiwan ETFs on AI boom, unnerving some RE
Vanguard World Fund - Vanguard Utilities ETF Reports Earnings Results for the Half Year Ended February 29, 2024 CI
Vanguard World Fund - Vanguard Energy ETF Reports Earnings Results for the Half Year Ended February 29, 2024 CI
Vanguard World Fund - Vanguard Communication Services ETF Reports Earnings Results for the Six Months Ended February 29, 2024 CI
Vanguard World Fund - Vanguard Industrials ETF Reports Earnings Results for the Half Year Ended February 29, 2024 CI
ETF of the week: Mexico's future looks golden Our Logo
IShares Trust - iShares Core U.S. Aggregate Bond ETF Reports Earnings Results for the Full Year Ended February 29, 2024 CI
IShares Trust - iShares 20+ Year Treasury Bond ETF Reports Earnings Results for the Full Year Ended February 29, 2024 CI
IShares Trust - iShares iBoxx $ Investment Grade Corporate Bond ETF Reports Earnings Results for the Half Year Ended February 29, 2024 CI
IShares Trust - iShares 7-10 Year Treasury Bond ETF Reports Earnings Results for the Full Year Ended February 29, 2024 CI
More news

ETF Ratings

Description

US92189F7261
Total Expense Ratio 0.35%
Asset Class
Sector
Size
Currency
Provider
Underlying MVIS US Listed Biotech 25 Net Total Return Index - USD

Features and characteristics

Jurisdiction
Fund Structure
Replication Method
Replication Model
Date of creation
19/12/2011
Dividend Policy
Geographical Focus

Distribution

Retail investor

AuM evolution ( 27/03/2024 )

AuM (EUR) 419 M€
AuM 1M 424 M€
AuM 3 months 444 M€
AuM 6 months 427 M€
AuM 12 months 450 M€
  1. Stock Market
  2. ETF
  3. BBH ETF
  4. News VanEck Biotech ETF - USD